Skip to main content Help with accessibility Skip to main navigation

Buprenorphine Patches

Indication

Pain, in patients who are unable to take or tolerate oral medicine, (including soluble tablets and liquids).
Green (Restricted)

Brand:

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

No

BNF chapter:
Central nervous system

Background

Transdermal preparations lack the flexibility required when treating patients with fluctuating or uncontrolled pain. Use should be reserved for patients with stable pain who are unable to take or tolerate oral medicines. Buprenorphine patches are several times more expensive than equivalent doses of oral analgesics, and inappropriate use of transdermal preparations has cost implications for commissioners. It is recommended that the reason for using a patch is documented on initiation and if appropriate patients are switched to oral formulations at the earliest opportunity.

Recommendation

LSCMMG Recommendation:

Green (Restricted)

Reason for decision:

Suitable for initiation in primary care in line with restrictions

Decisions of Lancashire local decision making groups

Pending
Pending
Grey
Pending
Amber 0
Grey
Black
Pending
What do the colours mean?

Last Updated: 01 - May - 2015